Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine the prevalence of moderate-to-severe Mitral Regurgitation (MR) in acute Heart Failure (HF) patients requiring hospital admission.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Metanoic Health Ltd.
Collaborators
NCT04761120 · Mitral Regurgitation, Tricuspid Regurgitation, and more
NCT03999138 · Acute Heart Failure, Pulmonary Edema With Heart Failure
NCT04688190 · Mitral Regurgitation, Mitral Valve Disease, and more
NCT07197736 · Valve Disease, Aortic, Mitral Regurgitation (MR), and more
NCT07527156 · Acute Heart Failure (AHF), Cardiogenic Shock, and more
St Peter's Hospital, Guildford Road
Chertsey, Surrey
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions